US 11680067
Small molecules for the treatment of primary cancer and cancer metastasis
granted A61KA61K31/522A61P
Quick answer
US patent 11680067 (Small molecules for the treatment of primary cancer and cancer metastasis) held by The Board of Regents of the University of Texas System expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/522, A61P, A61P35/00